DIGESTIVE AND KIDNEY DISEASES LIVER TRANSPLANTATION DATABASE symptoms, signs, biochemical laboratory test results, serology, radio-transplantation. (HEPATOLOGY 1996;24:89-96.) logical, and histological results as well as information on the transplantation procedure itself. Detailed information on t
Effect of donor age and sex on the outcome of liver transplantation
โ Scribed by Ignazio Roberto Marino; Howard R. Doyle; Luca Aldrighetti; Cataldo Doria; John McMichael; Timothy Gayowski; John J. Fung; Andreas G. Tzakis; Thomas E. Starzl
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 928 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
For acute liver failure (ALF), living donor liver transplantation (LDLT) may reduce waiting time and provide better timing compared to deceased donor liver transplantation (DDLT). However, there are concerns that a partial graft would result in reduced survival of critically ill LDLT recipients and
The exact frequency and clinical consequences of surgical hepatic injuries during organ procurement are unknown. We analyzed the incidence, risk factors, and clinical outcome of surgical injuries in 241 adult liver grafts. Hepatic injuries were categorized as parenchymal, vascular, or biliary. Outco
Hepatic steatosis is often associated with overweight, so we tried body-weight reduction in potential living donors with fatty liver and/or obesity to alleviate hepatic steatosis. We advised to reducing the body weight by 5% for 9 potential living donors showing hepatic steatosis of 25 -95% on initi
By virtue of size, the right liver graft has become the workhorse of adult-to-adult live donor liver transplantation (ALDLT). Although favorable results of left liver ALDLT have also been reported, a head-to-head comparison of these 2 graft types both containing the middle hepatic vein had not been
The study objectives were to determine whether the findings of the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) reflect the U.S. national experience and to define risk factors for patient mortality and graft loss in living donor liver transplantation (LDLT). A2ALL previousl